University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
NCT Number: NCT06507735
The purpose of our study is to investigate the effects of supplemental mannose on sera of humans who are healthy. We will perform proteomics studies to elucidate changes to glycan structure and protein level changes. We hypothesize that we may find that mannose supplies more properly glycosylated protein substrate and helps expedite protein synthesis, that excess mannose leads to alternative glycan structures which confer improved stability, or that there are new sites that become glycosylated after mannose supplementation.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Dallas, Texas, 75390, United States
Subjects will be enrolled and a baseline blood sample taken. Subjects will take mannose supplements for 1 week (3-4 packets of a standard dose in water), then a follow up blood sample will be taken.
Subject blood will be analyzed by proteomic analysis for 1) change in glycan structure or 2) other protein based approaches to measure changes in levels of proteins.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mannose is a sugar monomer that is important in the glycosylation of many proteins. The concentration of mannose in mammalian plasma is ~50-100 μM, which is primarily derived from N-glycan processing. Taking dietary mannose supplements can raise the levels of plasma mannose by 3- to 5-fold. There are currently no known adverse effects of mannose supplementation in humans.
Time frame: ~1 month
Glycopeptide mass spectrometry will be applied to the major glycoproteins present in serum.
Time frame: ~1 month
Standard laboratory methods such as ELISA in either research or clinical laboratory settings (Roche Cobas or similar platform).
University of Texas Southwestern Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02075424
Behavior, Behavioral Symptoms
Metz, France
View Trial DetailsNCT05603780
Cognition Disorders, Cognitive Dysfunction
Caen, France
View Trial DetailsNCT06633302
Body Temperature Changes, Fatigue
Ottawa, Ontario, Canada
View Trial DetailsNCT03867344
Glucose Metabolism Disorders, Hypoglycemia
Boston, Massachusetts, United States
View Trial Details